Skip to content
HowShorted

LENZ Therapeutics, Inc. short interest in 2021

In 2021, LENZ Therapeutics, Inc.'s disclosed short interest ran from 3.33% of shares outstanding on 13 Aug 2021 to 4.70% on 31 Dec 2021, a change of +1.37 percentage points. The year's high was 5.77% on 30 Sep 2021 and its low 3.33% on 13 Aug 2021, averaging 4.87% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.42 days on 29 Oct 2021. Full history: LENZ Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for LENZ Therapeutics, Inc. in 2021

2021 in figures

Start of year
3.33% (13 Aug 2021)
End of year
4.70% (31 Dec 2021)
Change
+1.37 pp
High
5.77% (30 Sep 2021)
Low
3.33% (13 Aug 2021)
Average
4.87%
Highest days to cover
22.42 (29 Oct 2021)
SEC filings marked
4

Every report in 2021

LENZ Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
13 Aug 20213.33%5.2810-Q filed, results (8-K)
31 Aug 20213.86%8.32
15 Sep 20214.68%10.35
30 Sep 20215.77%5.88
15 Oct 20215.42%11.52
29 Oct 20215.38%22.42
15 Nov 20215.08%21.7910-Q filed, results (8-K)
30 Nov 20215.04%12.95
15 Dec 20215.42%11.83
31 Dec 20214.70%8.04

See also: LENZ Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.